The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma - Wikidata - awgldk - TriplyDB

The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma

The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma

http://www.wikidata.org/entity/Q34515144

about

Advances in targeted therapies and new promising targets in esophageal cancer AXL kinase as a novel target for cancer therapy Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.The Receptor Tyrosine Kinase AXL in Cancer Progression Translational research in thoracic surgery-the National Taiwan University Hospital experience Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.Molecular pathways: niches in metastatic dormancy A comprehensive map of the human urinary proteome Increased frequency of single base substitutions in a population of transcripts expressed in cancer cells.The role of epithelial plasticity in prostate cancer dissemination and treatment resistance Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma Homing of cancer cells to the bone Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines AXL mediates TRAIL resistance in esophageal adenocarcinoma Phosphotyrosine profiling of curcumin-induced signaling.Biology of the TAM receptors.A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.Imaging Axl expression in pancreatic and prostate cancer xenografts.The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma.Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma.Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes.TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.ABL regulation by AXL promotes cisplatin resistance in esophageal cancer.AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review.Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking

P2860

Q26825957-B60D1ED6-A788-433F-A77B-A45F04179686 Q26863442-5B72830D-E444-4711-B852-814925B7C959 Q27026253-E8342C02-520E-4E3B-81EB-0E7E4F1AB6C0 Q27853383-69F5C532-2050-4C30-8BA8-5537420239E1 Q28068756-574A86C1-C821-46CB-9C20-21145853163A Q28073690-88C849A3-C956-4BBB-BB10-70CA23CC97B0 Q28085367-E105D424-CFC4-4DFF-ABCA-2E5D86083092 Q28588141-A00691BA-3879-4874-AA01-6B922E370F52 Q33733522-AF7E7CBE-B609-4FEC-AB61-AA93E4EC2D15 Q33838536-5E05B280-3D8D-488D-B6FE-672FF22BB3CA Q34424829-80E992B6-565B-42AF-A03B-F1C52FCE3555 Q34471093-1B1E3C49-1FE3-4637-A3BF-F5C9D0BA56FA Q34505037-9C87777A-4E9B-489D-92B0-D548997415FE Q34547790-C6C32F2A-F0EF-4C7D-B8E2-92951DE94002 Q35125173-882744DF-5C8B-4B29-8CEE-FE9467C12D38 Q35149569-B96F7166-2748-4DAD-BF60-E6F1D6220074 Q35603135-DEBA07AA-EE24-48D8-ADFA-8DD034B43B4D Q36044487-01CBE7F2-3431-4C86-AE30-2C6600A18865 Q36438319-0C5CECE7-E8F0-451E-ABB8-49C66699216E Q36670896-D2748719-4F3B-4937-9C69-23D10D87F4CA Q37006455-04CCD1B9-5B99-4BD7-A873-DEE4A1E5F9F2 Q37258717-F2BDCE9A-33A8-4F44-8591-D3FAE986851A Q37379468-E022C677-5AC5-4D90-9B23-E6FAA545EF7F Q37451822-9DDE9475-C8BD-4C6B-B00D-1A5562871103 Q37571724-356DE0F3-6690-4E17-A274-0DE1FAABB5DF Q38104686-6C279EBA-765E-48DB-A0E9-BA10414B33FB Q38491805-A327037B-2110-43F8-B179-A83482DABF80 Q38946773-E60509EA-B130-4B30-8EB8-A9BAD7D9B3EE Q39063025-BCEB4DEB-0F73-4D55-A5A8-FF080667F0E2 Q39144184-A24352C3-CC60-4A06-8998-636E451A7D93 Q39160959-0435D2FE-6F81-473A-AAD0-9AC9C0401B6C Q39250660-B9AE8DE7-A1B2-4B81-AB25-936E1C2CEEBF Q42359111-57936F79-B63E-4CD4-B63E-D9A1F7B66300 Q49238007-8D6FFEBE-78CB-4837-9F6C-18948258AC36 Q49887971-600098D8-3981-488E-8C4C-B1D05646D205 Q50113702-2BD44CCF-833B-45A0-9ECF-5AFD1ABF1FB9 Q52669235-C9DDF99F-D4DC-49A2-BB01-E0C3DC61A573 Q57143959-FB730F79-8865-4527-8019-CF2300AE4742

P2860

The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma

http://www.wikidata.org/entity/Q34515144

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@ast

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@en

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@nl

type

label

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@ast

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@en

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@nl

prefLabel

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@ast

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@en

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@nl

P1433

Q34515144-885D35B5-8EA9-49C7-B1C0-7A86BCCF5481

P1476

Q34515144-B19E3765-377E-471E-B441-4AFA1F24D253

P2093

Q34515144-12A8CA78-BAA0-4C7B-BB93-64E4B2D9527D

Q34515144-1748FAB1-11AA-4432-A253-0E2C087E4CD6

Q34515144-183F5D8E-3CB8-4025-B1EB-896B8B6238B7

Q34515144-1D3F2456-8D67-4A73-8AA3-FD12B5AA5750

Q34515144-3C3E6721-69CA-4E52-9F05-2344ECC61CBA

Q34515144-3FE7CDCF-81C7-4251-BEAB-80E90C81A36E

Q34515144-4B80DBA0-DFFD-4EB8-929C-EA787B4E340D

Q34515144-55052A13-6ED2-4363-B008-31407FA5CDDC

Q34515144-61BFB27F-1EC4-4B05-AD25-9608E690DE56

Q34515144-6F8855B0-9B6E-4D59-8316-882A49AF6812

P2860

Q34515144-026266C9-6442-4F86-96FD-298F4AC17317

Q34515144-0D4E9D75-5B9C-4813-B915-0FB13C29BBFD

Q34515144-128835C6-3508-49E3-8141-61ED9E274E25

Q34515144-14F52AD6-6077-4B47-A7FE-28C1AD7B0CC3

Q34515144-223B6FFD-F154-40D2-8348-3F0E917B3CFE

Q34515144-2326D74F-65EE-408E-B0D4-6D0C42342751

Q34515144-28D5E9C5-D5BA-49AA-8715-FF7D671A6B46

Q34515144-2B3F417C-0F01-45AB-B79B-B5EE1188C24B

Q34515144-2D412419-066B-4532-85DB-2B2C735517F7

Q34515144-303E237E-9D2B-4EAB-841F-1CE3641E6A47

P304

Q34515144-B4DC9D21-F5CC-464F-B001-059EC48CC208

P31

Q34515144-A2AFED1A-291E-4C9F-941B-9832576B117E

P356

Q34515144-1541A902-916F-4A71-9E02-3810BBFBC6D3

P433

Q34515144-E3952CE9-ED45-4A3A-B196-E890CF157A98

P478

Q34515144-04C9CB42-EA0A-47C8-885C-A3AC47A9FB01

P50

Q34515144-5BA1B507-4C07-46E2-A568-8420839F1708

Q34515144-608906A8-9955-4990-8CA7-FDB631F2F5E1

Q34515144-93656485-C26C-4F18-9CFE-A8A5AEDD87DD

P577

Q34515144-D56DAC79-B671-402B-A0B8-44B543714244

P5875

Q34515144-45B894A2-6B21-459C-9509-CF1B62A47253

P698

Q34515144-5A0C5C12-B0D9-4A10-B449-767CEFBB4AB4

P921

Q34515144-68C8B478-AA36-4895-AE86-8EBD028B3D28

P932

Q34515144-25AFABE4-F590-4354-911A-F77984FCDB6C

P356

CBT.10.10.13248

P1433

Cancer Biology and Therapy

P1476

The Axl receptor tyrosine kina ...... t in esophageal adenocarcinoma

@en

P2093

Akhilesh Pandey

http://www.w3.org/2001/XMLSchema#string

Alan K Meeker

http://www.w3.org/2001/XMLSchema#string

Alvarez Hector

http://www.w3.org/2001/XMLSchema#string

Arivusudar Marimuthu

http://www.w3.org/2001/XMLSchema#string

Barry D Nelkin

http://www.w3.org/2001/XMLSchema#string

Collins Karikari

http://www.w3.org/2001/XMLSchema#string

Dane Goff

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Montgomery

http://www.w3.org/2001/XMLSchema#string

Georg Feldmann

http://www.w3.org/2001/XMLSchema#string

Gregory J Riggins

http://www.w3.org/2001/XMLSchema#string

P2860

axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase

Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity

Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival

Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.

A putative effector of Ral has homology to Rho/Rac GTPase activating proteins

Stimulation of gene induction and cell growth by the Ras effector Rlf

The role of Ral A in epidermal growth factor receptor-regulated cell motility.

RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.

A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia.

A comparative analysis of the information content in long and short SAGE libraries

P304

1009-1018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.10.10.13248

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Juan Carlos Roa

P577

2010-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46149538

http://www.w3.org/2001/XMLSchema#string

P698

20818175

http://www.w3.org/2001/XMLSchema#string

P921

P932

3025816

http://www.w3.org/2001/XMLSchema#string